
    
      At baseline, standardized Geriatric Assessment (GA) tools incorporating subject reported data
      and bedside testing will be collected. HCT-Comorbidity Index (CI) scores will be assigned and
      C-reactive protein (CRP) and albumin will be measured locally. Serial measures at 3, 6, and
      12 months for frailty, skilled facility admission, and quality of life (QOL) using PROMIS
      measures for physical function, depression and anxiety will be determined. Graft Versus Host
      Disease (GVHD) through one year, serious toxicities through day 100, cognitive status at day
      100 and causes of death will be captured.
    
  